News und Analysen
EQS-News: VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings
EQS-News: VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO acquires an ethanol plant from Mercuria in South Bend/Indiana, USA.
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO acquires an ethanol plant from Mercuria in South Bend/Indiana, USA.
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO adjusts its forecast for the full financial year 2022/2023 and announces its preliminary EBITDA for the first nine months of the financial year
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO adjusts its forecast for the full financial year 2022/2023 and announces its preliminary EBITDA for the first nine months of the financial year
EQS-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance
EQS-Adhoc: Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance
EQS-News: Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177
EQS-News: Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177
EQS-News: Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
EQS-News: Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
EQS-News: Eckert & Ziegler: Successful fiscal year 2022
EQS-News: Eckert & Ziegler: Successful fiscal year 2022
EQS-News: Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO plans conversion into a European Company (Societas Europaea, SE).
EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO plans conversion into a European Company (Societas Europaea, SE).
EQS-News: VERBIO Vereinigte BioEnergie AG: Biomethane production again at a new record level in Q2 2022/23
EQS-News: VERBIO Vereinigte BioEnergie AG: Biomethane production again at a new record level in Q2 2022/23
EQS-News: Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
EQS-News: Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
EQS-Adhoc: Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures
EQS-Adhoc: Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures
EQS-News: Change in the Supervisory Board of Eckert & Ziegler AG
EQS-News: Change in the Supervisory Board of Eckert & Ziegler AG
EQS-Adhoc: Changes in the Management Board of Eckert & Ziegler
EQS-Adhoc: Changes in the Management Board of Eckert & Ziegler
EQS-Adhoc: Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR
EQS-Adhoc: Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR
EQS-News: VERBIO Vereinigte BioEnergie AG: makes a strong start in the new financial year
EQS-News: VERBIO Vereinigte BioEnergie AG: makes a strong start in the new financial year
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility